Established in 2004, Avivia is a specialized pharmaceutical development company engaged in CRO service activities, drug repositioning, repurposing and reformulation. Over the past ten years, the company has built a solid reputation recognized for its R&D flexibility and ‘out-of-the-box’ approach towards complex and challenging analytical and pharmaceutical development projects. Today, we are the preferred partner for many big pharma, specialty pharma, generic drug companies and smaller drug development firms. We operate a hybrid business model combining CRO service activities (both full development programs as well as stand-alone services) with internal product programs aimed at the development of value-added products. Our offices and state-of-the-art laboratories are located in Nijmegen, The Netherlands, in close proximity to the German and Belgian borders.
The Avivia management team combines the experiences of executives and a top-tier advisory board with extensive backgrounds in managing, developing and exiting successful businesses in the pharmaceutical and generics industry.
Johannes (‘Hans’) J. Platteeuw - Founder & CEO
Mr. Platteeuw holds a master’s degree in Chemistry from the University of Nijmegen, The Netherlands. He started his career at Synthon as Project Manager of pharmaceutical product development and later became the company’s Head of Galenical R&D. In this latter position, Mr. Platteeuw contributed to the development of Synthon’s R&D organization and product portfolio, including the granting of 10 worldwide patents. In 2004 he moved to Dafra Pharma, a private company specialized in antimalarial medication where he acted as Director R&D and was instrumental for the launch of Co-Arinate which provided an effective treatment of malaria within 24 hours and which ever since has been the top selling product of Dafra. In 2005, he started Avivia BV, an independent company specialized in pharmaceutical product development with a specific expertise in the development and intellectual property protection of specialty generics products. Through Avivia he has been hired by many companies in roles as project manager (Disphar, Organon/SP, Pharming, Virostatics, Genetic Immunity, Metaptys), chief operating officer (Formac Pharmaceuticals), chief development officer (Chamaeleo) or director pharmaceutical R&D (Pantarhei). For most of these companies his work resulted in further patent applications (15), licensing deals and significant market revenue.
Menno Wiltink - Project Leader and Head of Analytical R&D
Mr. Wiltink is a Partner in Avivia who has 25 years of experience in the pharmaceutical R&D with expertise in Analytical Research and Support, API, Excipient and Drug Product Characterization and Troubleshooting, Predictive Dissolution Testing, Preclinical Evaluation and Equivalence selection. He was Head Analytical Research at Synthon and studied Analytical Sciences at the University in Amsterdam and Environmental Analysis at the Van Hall Larenstein, University of Applied Sciences.
Dennie van den Heuvel - Project Leader and Head of Pharmaceutical R&D
Mr. van den Heuvel is a Partner in Avivia who has over 20 years working experience in the pharmaceutical industry and is an expert in formulation development. Related topics range from preclinical development up to the market formulation including production, IP and regulatory requirements. He held different positions at Intervet/Akzo-Nobel and Synthon and has extensive experience in project management, working in and leading/coaching interdisciplinary teams (CMC, Toxicology, Clinical, Regulatory, Analytics). He is an inventor of 25+ patents in name of Synthon.
Hans van der Steen - Project Leader and Manager of Operations
Mr. van der Steen is a Partner in Avivia and holds a bachelor's degree in analytical chemistry from the Fontys higher education of Eindhoven. After obtaining more than 10 years of experience in analytical chemistry in the pharmaceutical and excipient industry, Organon NV, CP Kelco and Synthon (Biopharmaceuticals), he joined Avivia in 2015. His area of interest and expertise includes API and excipient characterisation, analytical research & support and drug product troubleshooting & development. Apart from acting as a Project Leader, he is responsible for the daily operation of the company.
Avivia is growing so we are constantly looking for Senior Scientists (Pharmaceutical Development) to join our team and to help us achieve our goals. We are keen on people who say what they’ll do and do it, are 100% focused on results and success, have a strong personality (but not too strong), and want to work in pharma for the right reasons. If you are interested to join our team, don’t hesitate to let us know. Get in touch.
At Avivia we are proud of our development facilities and equipment, which enable us to perform formulation and analytical R&D at the highest level. A recent upgrade and expansion of the facilities provides even more flexibility and increased capacity of our services. We welcome all interested parties to visit us for a tour through our state-of-the-art facilities!
M-building – Novio Tech Campus
6534 AT Nijmegen, The Netherlands
Email info [at] avivia.nl
Phone - Reception +31 (0)6-1968-6732